Q3 2022 Holdings
Filed 2022-11-14 | 86 holdings | $954.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Globus MED Inc(GMED) | CL A | 379577208 | $44.5K | 747,685 | 0.0% |
| Cincor Pharma Inc | COM | 17240Y109 | $45.6K | 1,389,705 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $46.9K | 3,651,823 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $48.8K | 1,845,366 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $51.8K | 4,356,920 | 0.0% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $54.2K | 1,551,778 | 0.0% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $60.3K | 4,241,472 | 0.0% |
| Axonics Inc(AXNX*) | COM | 05465P101 | $62.3K | 884,974 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $65.0K | 3,625,000 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $71.9K | 3,099,904 | 0.0% |
| Cutera Inc(CUTREUR) | COM | 232109108 | $80.7K | 1,770,400 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $84.4K | 5,170,784 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $96.8K | 2,209,283 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $97.7K | 2,359,996 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $97.9K | 2,644,475 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $107.7K | 564,375 | 0.0% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $129.4K | 2,369,138 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $131.5K | 1,882,663 | 0.0% |
| Penumbra Inc(PEN) | COM | 70975L107 | $132.4K | 698,371 | 0.0% |
| Prometheus Biosciences Inc | COM | 74349U108 | $188.2K | 3,189,605 | 0.0% |
| Masimo Corp(MASI) | COM | 574795100 | $203.3K | 1,439,993 | 0.0% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $209.0K | 4,451,483 | 0.0% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $220.9K | 435,500 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $252.2K | 15,802,802 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $282.2K | 5,620,580 | 0.0% |
| Aadi Bioscience Inc(WHWK) | COM | 00032Q104 | $10.8M | 764,701 | 1.1% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $13.5M | 516,995 | 1.4% |
| Apyx Medical Corporation(APYX) | COM | 03837C106 | $15.3M | 3,398,279 | 1.6% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $24.7M | 2,819,472 | 2.6% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $29.7M | 1,276,276 | 3.1% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $60.1M | 3,670,938 | 6.3% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $84.0M | 1,882,164 | 8.8% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $86.7M | 3,084,215 | 9.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $124.7M | 2,574,198 | 13.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $164.9M | 467,195 | 17.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $336.9M | 1,683,362 | 35.3% |